{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:57:35Z","timestamp":1794851855696,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02953-x","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:28:15Z","timestamp":1760700495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence characteristics of human papillomavirus among women in Henan Province of China"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"23","key":"2953_CR1","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1002\/cncr.34485","volume":"128","author":"S Markovina","year":"2022","unstructured":"Markovina S, Rendle KA, Cohen AC, Kuroki LM, Grover S, Schwarz JK. Improving cervical cancer survival-a multifaceted strategy to sustain progress for this global problem. Cancer. 2022;128(23):4074\u201384.","journal-title":"Cancer"},{"key":"2953_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ Kombe Kombe","year":"2020","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2020;8:552028.","journal-title":"Front Public Health"},{"issue":"2","key":"2953_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11606-018-4732-z","volume":"34","author":"M Wei","year":"2019","unstructured":"Wei M, Zhou W, Bi Y, Wang H, Liu Y, Zhang ZJ. Rising mortality rate of cervical cancer in younger women in urban China. J Gen Intern Med. 2019;34(2):281\u20134.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"2953_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S de Sanjose","year":"2007","unstructured":"de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2953_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","volume":"16","author":"AAA Oyouni","year":"2023","unstructured":"Oyouni AAA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023;16(4):626\u201331.","journal-title":"J Infect Public Health"},{"issue":"4","key":"2953_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.idc.2013.09.001","volume":"27","author":"EF Dunne","year":"2013","unstructured":"Dunne EF, Park IU. HPV and HPV-associated diseases. Infect Dis Clin North Am. 2013;27(4):765\u201378.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"2953_CR7","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359.","journal-title":"Int J Cancer"},{"key":"2953_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.virol.2014.12.028","volume":"476","author":"D Bzhalava","year":"2015","unstructured":"Bzhalava D, Eklund C, Dillner J. International standardization and classification of human papillomavirus types. Virology. 2015;476:341\u20134.","journal-title":"Virology"},{"issue":"4","key":"2953_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens\u2013part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2953_CR10","first-page":"114","volume":"29","author":"K Syrjanen","year":"2008","unstructured":"Syrjanen K, Kulmala SM, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, et al. Epidemiological, clinical and viral determinants of the increased prevalence of high-risk human papillomavirus (HPV) infections in elderly women. Eur J Gynaecol Oncol. 2008;29(2):114\u201322.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"42","key":"2953_CR11","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.1016\/j.vaccine.2018.08.063","volume":"36","author":"MA Smith","year":"2018","unstructured":"Smith MA, Hall M, Lew JB, Canfell K. Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: example from New Zealand. Vaccine. 2018;36(42):6314\u201324.","journal-title":"Vaccine"},{"key":"2953_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25899","author":"J Liu","year":"2020","unstructured":"Liu J, Shi Y, Wang L, Wang J, Fan D, Han S, et al. Epidemiology and persistence of cervical human papillomavirus infection among outpatient women in Heilongjiang province: a retrospective cohort study. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25899.","journal-title":"J Med Virol"},{"issue":"4","key":"2953_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Mu\u00f1oz N, Meijer C. Shah KVJJocp: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"1","key":"2953_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Mu\u00f1oz NJTJop: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"key":"2953_CR15","doi-asserted-by":"crossref","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928\u201343.","DOI":"10.1056\/NEJMoa061760"},{"key":"2953_CR16","doi-asserted-by":"crossref","unstructured":"Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;372(8):711\u201323.","DOI":"10.1056\/NEJMoa1405044"},{"issue":"16","key":"2953_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/cncr.32986","volume":"126","author":"Y Lu","year":"2020","unstructured":"Lu Y, Li P, Luo G, Liu D, Zou H. Cancer attributable to human papillomavirus infection in China: burden and trends. Cancer. 2020;126(16):3719\u201332.","journal-title":"Cancer"},{"issue":"1","key":"2953_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12985-023-01959-7","volume":"20","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo N, Li B, Shang E, Wang J, Zhang M, et al. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020. Virol J. 2023;20(1):11.","journal-title":"Virol J"},{"issue":"1","key":"2953_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96131-y","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Yu C, Ni X, Wang F, Wen C, Jin M, et al. Prevalence characteristics of human papillomavirus (HPV) infection among women receiving physical examinations in the Shangcheng District, Hangzhou city, China. Sci Rep. 2021;11(1):16538.","journal-title":"Sci Rep"},{"issue":"1","key":"2953_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandongs largest independent pathology laboratory. PLoS ONE. 2019;14(1):e0210311.","journal-title":"PLoS ONE"},{"issue":"4","key":"2953_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s11596-019-2083-6","volume":"39","author":"QF Ma","year":"2019","unstructured":"Ma QF, Guo YL, Gao H, Yan B, Dai X, Xu M, et al. Prevalence and determinants of high-risk HPV infection among 11549 women from an opportunistic screening in Hubei Province. Curr Med Sci. 2019;39(4):622\u201330.","journal-title":"Curr Med Sci"},{"key":"2953_CR22","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10179","volume":"8","author":"L Peng","year":"2020","unstructured":"Peng L, Yin L, Dai Y, Peng Y, Xu Y, Hu H, et al. Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China. PeerJ. 2020;8:e10179.","journal-title":"PeerJ"},{"issue":"1","key":"2953_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-021-01732-8","volume":"19","author":"X Wang","year":"2022","unstructured":"Wang X, Song Y, Wei X, Wang G, Sun R, Wang M, et al. Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China. Virol J. 2022;19(1):6.","journal-title":"Virol J"},{"issue":"7","key":"2953_CR24","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cncr.32003","volume":"125","author":"K Li","year":"2019","unstructured":"Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer. 2019;125(7):1030\u20137.","journal-title":"Cancer"},{"issue":"6","key":"2953_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. International agency for research on cancer multicenter cervical cancer study G: epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"1","key":"2953_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00404-022-06653-7","volume":"308","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhang S. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women. Arch Gynecol Obstet. 2023;308(1):35\u201341.","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"2953_CR27","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399.","journal-title":"J Infect Dis"},{"issue":"6","key":"2953_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s11764-021-01000-2","volume":"15","author":"B Cherven","year":"2021","unstructured":"Cherven B, Klosky JL, Chen Y, York JM, Heaton K, Childs G, et al. Sexual behaviors and human papillomavirus vaccine non-initiation among young adult cancer survivors. J Cancer Surviv. 2021;15(6):942\u201350.","journal-title":"J Cancer Surviv"},{"issue":"7","key":"2953_CR29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/infdis\/jiz238","volume":"220","author":"MD Wissing","year":"2019","unstructured":"Wissing MD, Louvanto K, Comete E, Burchell AN, El-Zein M, Rodrigues A, et al. Human papillomavirus viral load and transmission in young, recently formed heterosexual couples. J Infect Dis. 2019;220(7):1152\u201361.","journal-title":"J Infect Dis"},{"issue":"12","key":"2953_CR30","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","volume":"19","author":"P Gonzalez","year":"2010","unstructured":"Gonzalez P, Hildesheim A, Rodriguez AC, Schiffman M, Porras C, Wacholder S, et al. Behavioral\/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3044\u201354.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2953_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pop.2020.05.007","volume":"47","author":"MS Khan","year":"2020","unstructured":"Khan MS, Savoy M. Impact of human papillomavirus vaccination in reducing cancer. Prim Care. 2020;47(3):529\u201337.","journal-title":"Prim Care"},{"issue":"10224","key":"2953_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575\u201390.","journal-title":"Lancet"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02953-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:28:17Z","timestamp":1760700497000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02953-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02953-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the ethical guidelines of the Declaration of Helsinki and was approved by Ethics Committee of the First Affiliated Hospital of Zhengzhou University. Since this study was a retrospective study and the patients private information was not involved in the study, therefore, formal consent was waived in our hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}